Keystone: Pulse-Chasing AD Biomarkers, Snaring γ-Secretase Targets
Two things you can find on any Alzheimerologist’s wish list are better drug targets and better diagnostics...
ALL NEWS
612 RESULTS
Sort By:
- Most Recent
- Most Commented
Research Brief: New Methods for Aβ Detection, Production
So many different Aβs to measure, so little time—and funds...
DIAN Part 2: The Science, Inner Workings of the Network
Scientifically, the Dominantly Inherited Alzheimer Network (DIAN) will test three hypotheses...
Worldwide ADNIs: Other Nations Follow Suit
Around the time the North American ADNI started, similar efforts sprang up in countries across the globe...
Bumps Along the Way—ADNI’s Snafus
By common consensus of some 20 investigators contacted for this story from within and without ADNI, this behemoth study is working well overall...
More ADNI Results 2: It’s All About Power
One goal of ADNI is to make clinical trials sharper...
Hot Plasma—Blood Aβ a Risk Marker for AD?
Among the plethora of factors that might serve as useful biomarkers for AD, perhaps none draws as much scrutiny as plasma amyloid-β...
BACE1 Gets Attention as Potential Alzheimer’s Biomarker
Recent work indicates that CSF BACE activity is significantly increased in people with AD...
eFAD News: Biomarkers May Help Pinpoint Disease Onset
People affected by early-onset familial forms (eFAD) often wonder how discoveries apply to them...
Plasma Aβ Testing Beset by Questions of Assays, Biology, Timing
Researchers led by Oskar Hansson at Lund University, Sweden, have developed a highly sensitive assay for plasma Aβ...
Metabolomics Reveals Changes in CSF in Model of HIV Dementia
A scan of cerebrospinal fluid from SIV-infected monkeys turned up potential markers of central nervous system disease...
A New Test for Alzheimer Disease?
A company recently announced that it will start marketing a blood test for Alzheimer disease within the year...
Alzheimer Activism: How To Modernize Clinical Trials?
On March 13, Alzheimer disease activist groups met with representatives from the FDA, clinicians, and industry leaders to discuss ways to improve clinical trials for candidate AD drugs...
A Blood Test for AD?
Plasma cholesterol measurements have done wonders for cardiovascular disease management...
AD Diagnosis: Time for Biomarkers to Weigh In?
Is it time for a new diagnostic paradigm for Alzheimer disease?...
Current Filters
- Biomarkers x